These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 21940589

  • 1. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE, Nesbit GM, Dosa E, Gahramanov S, Rooney B, Nesbit EG, Raines J, Neuwelt EA.
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [Abstract] [Full Text] [Related]

  • 2. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S, Raslan AM, Muldoon LL, Hamilton BE, Rooney WD, Varallyay CG, Njus JM, Haluska M, Neuwelt EA.
    Int J Radiat Oncol Biol Phys; 2011 Feb 01; 79(2):514-23. PubMed ID: 20395065
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging of intracranial tumors: intra-patient comparison of gadoteridol and ferumoxytol.
    Dósa E, Guillaume DJ, Haluska M, Lacy CA, Hamilton BE, Njus JM, Rooney WD, Kraemer DF, Muldoon LL, Neuwelt EA.
    Neuro Oncol; 2011 Feb 01; 13(2):251-60. PubMed ID: 21163809
    [Abstract] [Full Text] [Related]

  • 4. Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas.
    Horváth A, Varallyay CG, Schwartz D, Toth GB, Netto JP, Barajas R, Várallyay P, Szidonya L, Firkins J, Youngers E, Fu R, Ambady P, Bogner P, Neuwelt EA.
    Magn Reson Med; 2018 Jul 01; 80(1):224-230. PubMed ID: 29205477
    [Abstract] [Full Text] [Related]

  • 5. Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival.
    Gahramanov S, Muldoon LL, Varallyay CG, Li X, Kraemer DF, Fu R, Hamilton BE, Rooney WD, Neuwelt EA.
    Radiology; 2013 Mar 01; 266(3):842-52. PubMed ID: 23204544
    [Abstract] [Full Text] [Related]

  • 6. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
    Neuwelt EA, Várallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM.
    Neurosurgery; 2007 Apr 01; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
    [Abstract] [Full Text] [Related]

  • 7. Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.
    Varallyay CG, Nesbit E, Horvath A, Varallyay P, Fu R, Gahramanov S, Muldoon LL, Li X, Rooney WD, Neuwelt EA.
    J Magn Reson Imaging; 2018 Aug 01; 48(2):441-448. PubMed ID: 29314418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J, Neuwelt A, Eberhardt S, Mlady G, Shukla U, Murali S, Pizanis C, Sillerud LO.
    Magn Reson Imaging; 2020 Sep 01; 71():45-54. PubMed ID: 32439428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE, Barajas R, Nesbit GM, Fu R, Ambady P, Taylor M, Neuwelt EA.
    AJR Am J Roentgenol; 2020 Dec 01; 215(6):1436-1442. PubMed ID: 33052739
    [Abstract] [Full Text] [Related]

  • 12. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T.
    Colbert CM, Ming Z, Pogosyan A, Finn JP, Nguyen KL.
    J Magn Reson Imaging; 2023 Jun 01; 57(6):1819-1829. PubMed ID: 36250695
    [Abstract] [Full Text] [Related]

  • 13. Combined iron oxide nanoparticle ferumoxytol and gadolinium contrast enhanced MRI define glioblastoma pseudoprogression.
    Barajas RF, Hamilton BE, Schwartz D, McConnell HL, Pettersson DR, Horvath A, Szidonya L, Varallyay CG, Firkins J, Jaboin JJ, Kubicky CD, Raslan AM, Dogan A, Cetas JS, Ciporen J, Han SJ, Ambady P, Muldoon LL, Woltjer R, Rooney WD, Neuwelt EA.
    Neuro Oncol; 2019 Mar 18; 21(4):517-526. PubMed ID: 30277536
    [Abstract] [Full Text] [Related]

  • 14. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA, Campeau NG, Carr CM, Diehn FE, McDonald JS, Miller GM, Kaufmann TJ.
    Neuroradiology; 2016 Nov 18; 58(11):1087-1091. PubMed ID: 27704163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
    Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry KG, Caillé JM.
    AJNR Am J Neuroradiol; 1999 Feb 18; 20(2):223-7. PubMed ID: 10094342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model.
    Runge VM, Wells JW, Williams NM.
    Invest Radiol; 1997 Apr 18; 32(4):212-7. PubMed ID: 9101356
    [Abstract] [Full Text] [Related]

  • 19. Delineation of gliomas with various doses of MR contrast material.
    Yuh WT, Nguyen HD, Tali ET, Mayr NA, Fisher DJ, Atlas SW, Carvlin MC, Drayer BP, Pollei SR, Runge VM.
    AJNR Am J Neuroradiol; 1994 May 18; 15(5):983-9. PubMed ID: 8059672
    [Abstract] [Full Text] [Related]

  • 20. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM, Yerneni K, Theruvath AJ, Thakor AS, Pribnow A, Avedian R, Steffner R, Rosenberg J, Hawk KE, Daldrup-Link HE.
    Mol Imaging Biol; 2020 Jun 18; 22(3):722-729. PubMed ID: 31325083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.